IDEAS home Printed from https://ideas.repec.org/a/nat/nature/v555y2018i7696d10.1038_nature25480.html
   My bibliography  Save this article

The landscape of genomic alterations across childhood cancers

Author

Listed:
  • Susanne N. Gröbner

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Barbara C. Worst

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Joachim Weischenfeldt

    (European Molecular Biology Laboratory (EMBL), Genome Biology Unit
    The Finsen Laboratory, Rigshospitalet, Biotech Research and Innovation Centre (BRIC), Copenhagen University)

  • Ivo Buchhalter

    (German Cancer Research Center (DKFZ))

  • Kortine Kleinheinz

    (German Cancer Research Center (DKFZ))

  • Vasilisa A. Rudneva

    (European Molecular Biology Laboratory (EMBL), Genome Biology Unit
    St Jude Children’s Research Hospital)

  • Pascal D. Johann

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Gnana Prakash Balasubramanian

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ))

  • Maia Segura-Wang

    (European Molecular Biology Laboratory (EMBL), Genome Biology Unit)

  • Sebastian Brabetz

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Sebastian Bender

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ))

  • Barbara Hutter

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ))

  • Dominik Sturm

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Elke Pfaff

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Daniel Hübschmann

    (Hematology & Immunology, Heidelberg University Hospital
    German Cancer Research Center (DKFZ)
    Institute of Pharmacy and Molecular Biotechnology, Heidelberg University and BioQuant Center)

  • Gideon Zipprich

    (German Cancer Research Center (DKFZ))

  • Michael Heinold

    (German Cancer Research Center (DKFZ)
    Institute of Pharmacy and Molecular Biotechnology, Heidelberg University and BioQuant Center)

  • Jürgen Eils

    (German Cancer Research Center (DKFZ))

  • Christian Lawerenz

    (German Cancer Research Center (DKFZ))

  • Serap Erkek

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    European Molecular Biology Laboratory (EMBL), Genome Biology Unit)

  • Sander Lambo

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Sebastian Waszak

    (European Molecular Biology Laboratory (EMBL), Genome Biology Unit)

  • Claudia Blattmann

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Klinikum Stuttgart - Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie)

  • Arndt Borkhardt

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Clinical Immunology, University Children’s Hospital, Heinrich Heine University)

  • Michaela Kuhlen

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Clinical Immunology, University Children’s Hospital, Heinrich Heine University)

  • Angelika Eggert

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Charité-Universitätsmedizin Berlin)

  • Simone Fulda

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Institute for Experimental Cancer Research in Pediatrics, University Hospital Frankfurt)

  • Manfred Gessler

    (Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, and Comprehensive Cancer Center Mainfranken, University of Würzburg)

  • Jenny Wegert

    (Theodor-Boveri-Institute/Biocenter, Developmental Biochemistry, and Comprehensive Cancer Center Mainfranken, University of Würzburg)

  • Roland Kappler

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Research Laboratories, Dr von Hauner Children’s Hospital, Ludwig Maximilians University Munich)

  • Daniel Baumhoer

    (Bone Tumor Reference Center at the Institute of Pathology, University Hospital Basel and University of Basel)

  • Stefan Burdach

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Klinikum rechts der Isar, Technische Universität München)

  • Renate Kirschner-Schwabe

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Charité-Universitätsmedizin Berlin)

  • Udo Kontny

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    University Medical Center Aachen)

  • Andreas E. Kulozik

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Dietmar Lohmann

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    University Hospital Essen)

  • Simone Hettmer

    (University Medical Center Freiburg)

  • Cornelia Eckert

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Charité-Universitätsmedizin Berlin)

  • Stefan Bielack

    (Klinikum Stuttgart - Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie)

  • Michaela Nathrath

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Klinikum rechts der Isar, Technische Universität München
    Klinikum Kassel)

  • Charlotte Niemeyer

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    University Medical Center Freiburg)

  • Günther H. Richter

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Klinikum rechts der Isar, Technische Universität München)

  • Johannes Schulte

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Charité-Universitätsmedizin Berlin)

  • Reiner Siebert

    (Institute of Human Genetics, University of Ulm & University Hospital of Ulm)

  • Frank Westermann

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ))

  • Jan J. Molenaar

    (Princess Máxima Center for Pediatric Oncology)

  • Gilles Vassal

    (Gustave Roussy, Université Paris-Saclay)

  • Hendrik Witt

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Birgit Burkhardt

    (Pediatric Hematology and Oncology, University Hospital Münster)

  • Christian P. Kratz

    (Pediatric Hematology and Oncology, Hannover Medical School)

  • Olaf Witt

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital
    Clinical Cooperation Unit Pediatric Oncology, German Cancer Research Center (DKFZ))

  • Cornelis M. van Tilburg

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Center for Individualized Pediatric Oncology (ZIPO) and Brain Tumors, University Hospital and German Cancer Research Center (DKFZ))

  • Christof M. Kramm

    (University Medical Center Göttingen)

  • Gudrun Fleischhack

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Pediatric Oncology & Hematology, Pediatrics III, University Hospital of Essen)

  • Uta Dirksen

    (Pediatric Oncology & Hematology, Pediatrics III, University Hospital of Essen)

  • Stefan Rutkowski

    (University Medical Center Hamburg-Eppendorf)

  • Michael Frühwald

    (Swabian Children’s Cancer Center, Children’s Hospital, Klinikum Augsburg)

  • Katja von Hoff

    (University Medical Center Hamburg-Eppendorf)

  • Stephan Wolf

    (Genomics and Proteomics Core Facility, High Throughput Sequencing Unit, German Cancer Research Center (DKFZ))

  • Thomas Klingebiel

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hospital for Children and Adolescents, University Hospital Frankfurt)

  • Ewa Koscielniak

    (Klinikum Stuttgart - Olgahospital, Zentrum für Kinder-, Jugend- und Frauenmedizin, Pädiatrie)

  • Pablo Landgraf

    (University Hospital Cologne, Klinik und Poliklinik für Kinder- und Jugendmedizin)

  • Jan Koster

    (Academic Medical Center)

  • Adam C. Resnick

    (Center for Childhood Cancer Research, Children’s Hospital of Philadelphia)

  • Jinghui Zhang

    (St Jude Children’s Research Hospital)

  • Yanling Liu

    (St Jude Children’s Research Hospital)

  • Xin Zhou

    (St Jude Children’s Research Hospital)

  • Angela J. Waanders

    (Center for Childhood Cancer Research, Children’s Hospital of Philadelphia)

  • Danny A. Zwijnenburg

    (Academic Medical Center)

  • Pichai Raman

    (Center for Childhood Cancer Research, Children’s Hospital of Philadelphia)

  • Benedikt Brors

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ))

  • Ursula D. Weber

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ))

  • Paul A. Northcott

    (German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    St Jude Children’s Research Hospital)

  • Kristian W. Pajtler

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

  • Marcel Kool

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Rosario M. Piro

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ)
    Institute of Computer Science, Freie Universität Berlin
    Institute of Medical Genetics and Human Genetics, Charité University Hospital)

  • Jan O. Korbel

    (European Molecular Biology Laboratory (EMBL), Genome Biology Unit)

  • Matthias Schlesner

    (German Cancer Research Center (DKFZ)
    Bioinformatics and Omics Data Analysis, German Cancer Research Center (DKFZ))

  • Roland Eils

    (German Cancer Research Center (DKFZ)
    Institute of Pharmacy and Molecular Biotechnology, Heidelberg University and BioQuant Center)

  • David T. W. Jones

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Peter Lichter

    (German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    German Cancer Research Center (DKFZ))

  • Lukas Chavez

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ))

  • Marc Zapatka

    (German Cancer Research Center (DKFZ)
    Institute of Computer Science, Freie Universität Berlin)

  • Stefan M. Pfister

    (Hopp-Children’s Cancer Center at the NCT Heidelberg (KiTZ)
    German Cancer Research Center (DKFZ)
    German Cancer Consortium (DKTK), German Cancer Research Center (DKFZ)
    Hematology & Immunology, Heidelberg University Hospital)

Abstract

Pan-cancer analyses that examine commonalities and differences among various cancer types have emerged as a powerful way to obtain novel insights into cancer biology. Here we present a comprehensive analysis of genetic alterations in a pan-cancer cohort including 961 tumours from children, adolescents, and young adults, comprising 24 distinct molecular types of cancer. Using a standardized workflow, we identified marked differences in terms of mutation frequency and significantly mutated genes in comparison to previously analysed adult cancers. Genetic alterations in 149 putative cancer driver genes separate the tumours into two classes: small mutation and structural/copy-number variant (correlating with germline variants). Structural variants, hyperdiploidy, and chromothripsis are linked to TP53 mutation status and mutational signatures. Our data suggest that 7–8% of the children in this cohort carry an unambiguous predisposing germline variant and that nearly 50% of paediatric neoplasms harbour a potentially druggable event, which is highly relevant for the design of future clinical trials.

Suggested Citation

  • Susanne N. Gröbner & Barbara C. Worst & Joachim Weischenfeldt & Ivo Buchhalter & Kortine Kleinheinz & Vasilisa A. Rudneva & Pascal D. Johann & Gnana Prakash Balasubramanian & Maia Segura-Wang & Sebast, 2018. "The landscape of genomic alterations across childhood cancers," Nature, Nature, vol. 555(7696), pages 321-327, March.
  • Handle: RePEc:nat:nature:v:555:y:2018:i:7696:d:10.1038_nature25480
    DOI: 10.1038/nature25480
    as

    Download full text from publisher

    File URL: https://www.nature.com/articles/nature25480
    File Function: Abstract
    Download Restriction: Access to the full text of the articles in this series is restricted.

    File URL: https://libkey.io/10.1038/nature25480?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    As the access to this document is restricted, you may want to search for a different version of it.

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Albert Stuart Reece & Gary Kenneth Hulse, 2022. "Epidemiology of Δ8THC-Related Carcinogenesis in USA: A Panel Regression and Causal Inferential Study," IJERPH, MDPI, vol. 19(13), pages 1-27, June.
    2. Albert Stuart Reece & Gary Kenneth Hulse, 2022. "Epigenomic and Other Evidence for Cannabis-Induced Aging Contextualized in a Synthetic Epidemiologic Overview of Cannabinoid-Related Teratogenesis and Cannabinoid-Related Carcinogenesis," IJERPH, MDPI, vol. 19(24), pages 1-57, December.
    3. Samuel Rivero-Hinojosa & Melanie Grant & Aswini Panigrahi & Huizhen Zhang & Veronika Caisova & Catherine M. Bollard & Brian R. Rood, 2021. "Proteogenomic discovery of neoantigens facilitates personalized multi-antigen targeted T cell immunotherapy for brain tumors," Nature Communications, Nature, vol. 12(1), pages 1-15, December.
    4. Ting Liu & Jianan Rao & Wenting Hu & Bowen Cui & Jiaoyang Cai & Yuhan Liu & Huiying Sun & Xiaoxiao Chen & Yanjing Tang & Jing Chen & Xiang Wang & Han Wang & Wubin Qian & Binchen Mao & Sheng Guo & Rong, 2022. "Distinct genomic landscape of Chinese pediatric acute myeloid leukemia impacts clinical risk classification," Nature Communications, Nature, vol. 13(1), pages 1-11, December.
    5. Hanbing Song & Simon Bucher & Katherine Rosenberg & Margaret Tsui & Deviana Burhan & Daniel Hoffman & Soo-Jin Cho & Arun Rangaswami & Marcus Breese & Stanley Leung & María V. Pons Ventura & E. Alejand, 2022. "Single-cell analysis of hepatoblastoma identifies tumor signatures that predict chemotherapy susceptibility using patient-specific tumor spheroids," Nature Communications, Nature, vol. 13(1), pages 1-15, December.
    6. Joanna Szydzik & Dan E. Lind & Badrul Arefin & Yeshwant Kurhe & Ganesh Umapathy & Joachim Tetteh Siaw & Arne Claeys & Jonatan L. Gabre & Jimmy Eynden & Bengt Hallberg & Ruth H. Palmer, 2021. "ATR inhibition enables complete tumour regression in ALK-driven NB mouse models," Nature Communications, Nature, vol. 12(1), pages 1-18, December.
    7. John K. L. Wong & Christian Aichmüller & Markus Schulze & Mario Hlevnjak & Shaymaa Elgaafary & Peter Lichter & Marc Zapatka, 2022. "Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions," Nature Communications, Nature, vol. 13(1), pages 1-13, December.
    8. Yong Yean Kim & Berkley E. Gryder & Ranuka Sinniah & Megan L. Peach & Jack F. Shern & Abdalla Abdelmaksoud & Silvia Pomella & Girma M. Woldemichael & Benjamin Z. Stanton & David Milewski & Joseph J. B, 2024. "KDM3B inhibitors disrupt the oncogenic activity of PAX3-FOXO1 in fusion-positive rhabdomyosarcoma," Nature Communications, Nature, vol. 15(1), pages 1-19, December.
    9. Yanling Liu & Jonathon Klein & Richa Bajpai & Li Dong & Quang Tran & Pandurang Kolekar & Jenny L. Smith & Rhonda E. Ries & Benjamin J. Huang & Yi-Cheng Wang & Todd A. Alonzo & Liqing Tian & Heather L., 2023. "Etiology of oncogenic fusions in 5,190 childhood cancers and its clinical and therapeutic implication," Nature Communications, Nature, vol. 14(1), pages 1-18, December.
    10. Jie Fang & Shivendra Singh & Changde Cheng & Sivaraman Natarajan & Heather Sheppard & Ahmed Abu-Zaid & Adam D. Durbin & Ha Won Lee & Qiong Wu & Jacob Steele & Jon P. Connelly & Hongjian Jin & Wenan Ch, 2023. "Genome-wide mapping of cancer dependency genes and genetic modifiers of chemotherapy in high-risk hepatoblastoma," Nature Communications, Nature, vol. 14(1), pages 1-27, December.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:nature:v:555:y:2018:i:7696:d:10.1038_nature25480. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    We have no bibliographic references for this item. You can help adding them by using this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.